Kidney transplantation: Recent developments and recommendations for anesthetic management

Anesthesiology Clinics of North America

Volumn 22, Issue 4, 2004, Pages 651-662

  Lemmens, Harry J M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALFENTANIL; DESFLURANE; DESMOPRESSIN; DIAZEPAM; DOPAMINE; ENFLURANE; FENOLDOPAM; FENTANYL; FUROSEMIDE; ISOFLURANE; MANNITOL; METHOXYFLURANE; MIDAZOLAM; MIVACURIUM; MORPHINE; MORPHINE 6 BETA GLUCURONIDE; MORPHINE DERIVATIVE; MUSCLE RELAXANT AGENT; NORPETHIDINE; OPIATE; PANCURONIUM; PETHIDINE; PROPOFOL; REMIFENTANIL; ROCURONIUM; SEVOFLURANE; SUFENTANIL; SUXAMETHONIUM; THIOPENTAL; UNCLASSIFIED DRUG; VECURONIUM;

ANEMIA; ANESTHESIA; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; COMORBIDITY; CRYOPRECIPITATE; DRUG SAFETY; EXERCISE TEST; EXERCISE TOLERANCE; HEART MUSCLE PERFUSION; HEMODIALYSIS; HEMODYNAMICS; HEPATITIS C; HUMAN; HYPERKALEMIA; HYPOTENSION; INCIDENCE; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; NEPHROTOXICITY; NONHUMAN; PREOPERATIVE EVALUATION; PREOPERATIVE PERIOD; PROGNOSIS; PULMONARY HYPERTENSION; REVIEW; SEIZURE; SIDE EFFECT; SURVIVAL RATE;

ANESTHESIA; ANESTHETICS; ANIMALS; HUMANS; KIDNEY TRANSPLANTATION; PREOPERATIVE CARE;

EID: 8444241126     PISSN: 08898537     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atc.2004.05.007     Document Type: Review

References (99)

1. Wolfe R.A., Ashby V.B., Milford E.L., Ojo A.O., Ettenger R.E., Agodoa L.Y., et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 341(23):1999;1725-1730
2. Rabbat C.G., Thorpe K.E., Russell J.D., Churchill D.N. Comparison of mortality risk for dialysis patients and cadaveric first renal transplant recipients in Ontario, Canada. J Am Soc Nephrol. 11(5):2000;917-922
3. Ojo A.O., Hanson J.A., Meier-Kriesche H., Okechukwu C.N., Wolfe R.A., Leichtman A.B., et al. Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. J Am Soc Nephrol. 12(3):2001;589-597
4. Meier-Kriesche H.U., Port F.K., Ojo A.O., Rudich S.M., Hanson J.A., Cibrik D.M., et al. Effect of waiting time on renal transplant outcome. Kidney Int. 58(3):2000;1311-1317
5. Brunkhorst R., Lufft V., Dannenberg B., Kliem V., Tusch G., Pichlmayr R. Improved survival in patients with type 1 diabetes mellitus after renal transplantation compared with hemodialysis: a case-control study. Transplantation. 76(1):2003;115-119
6. Ferreira S.R., Moises V.A., Tavares A., Pacheco-Silva A. Cardiovascular effects of successful renal transplantation: a 1-year sequential study of left ventricular morphology and function, and 24-hour blood pressure profile. Transplantation. 74(11):2002;1580-1587
7. Vandam L.D., Harrison J.H., Murray J.E., Merrill J.P. Anesthetic aspects of renal homotransplantation in man. With notes on the anesthetic care of the uremic patient. Anesthesiology. 23:1962;783-792
8. Strunin L. Some aspects of anaesthesia for renal homotransplantation. Br J Anaesth. 38(10):1966;812-822
9. Gill J.S., Pereira B.J. Death in the first year after kidney transplantation: implications for patients on the transplant waiting list. Transplantation. 75(1):2003;113-117
10. Danovitch G.M., Cecka J.M. Allocation of deceased donor kidneys: past, present, and future. Am J Kidney Dis. 42(5):2003;882-890
11. The Organ Procurement and Transplantation Network: data - waiting list candidates. Available at: http://www.optn.org/latestData/rptData.asp. Accessed: January, 2004
12. Danovitch G.M., Hariharan S., Pirsch J.D., Rush D., Roth D., Ramos E., et al. Management of the waiting list for cadaveric kidney transplants: report of a survey and recommendations by the Clinical Practice Guidelines Committee of the American Society of Transplantation. J Am Soc Nephrol. 13(2):2002;528-535
13. US Renal Data System. USRD 2003 annual data report: atlas of end stage renal disease in the United States. 2003;National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD
14. Locatelli F., Bommer J., London G.M., Martin-Malo A., Wanner C., Yaqoob M., et al. Cardiovascular disease determinants in chronic renal failure: clinical approach and treatment. Nephrol Dial Transplant. 16(3):2001;459-468
15. Arici M., Walls J. End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link? Kidney Int. 59(2):2001;407-414
16. Lagrand W.K., Visser C.A., Hermens W.T., Niessen H.W., Verheugt F.W., Wolbink G.J., et al. C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon? Circulation. 100(1):1999;96-102
17. Herzog C.A., Ma J.Z., Collins A.J. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med. 339(12):1998;799-805
18. Oh J., Wunsch R., Turzer M., Bahner M., Raggi P., Querfeld U., et al. Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation. 106(1):2002;100-105
19. Foley R.N., Parfrey P.S., Sarnak M.J. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 32(Suppl 3):1998;S112-S119
20. Steinman T.I., Becker B.N., Frost A.E., Olthoff K.M., Smart F.W., Suki W.N., et al. Guidelines for the referral and management of patients eligible for solid organ transplantation. Transplantation. 71(9):2001;1189-1204
21. Kasiske B.L., Cangro C.B., Hariharan S., Hricik D.E., Kerman R.H., Roth D., et al. The evaluation of renal transplantation candidates: clinical practice guidelines. Am J Transplant. 1(Suppl 2):2002;1-95
22. Holley J.L., Fenton R.A., Arthur R.S. Thallium stress testing does not predict cardiovascular risk in diabetic patients with end-stage renal disease undergoing cadaveric renal transplantation. Am J Med. 90(5):1991;563-570
23. Rabbat C.G., Treleaven D.J., Russell J.D., Ludwin D., Cook D.J. Prognostic value of myocardial perfusion studies in patients with end-stage renal disease assessed for kidney or kidney-pancreas transplantation: a meta-analysis. J Am Soc Nephrol. 14(2):2003;431-439
24. Yigla M., Nakhoul F., Sabag A., Tov N., Gorevich B., Abassi Z., et al. Pulmonary hypertension in patients with end-stage renal disease. Chest. 123(5):2003;1577-1582
25. Jubelirer S.J. Hemostatic abnormalities in renal disease. Am J Kidney Dis. 5(5):1985;219-225
26. Nampoory M.R., Das K.C., Johny K.V., Al-Hilali N., Abraham M., Easow S., et al. Hypercoagulability, a serious problem in patients with ESRD on maintenance hemodialysis, and its correction after kidney transplantation. Am J Kidney Dis. 42(4):2003;797-805
27. Fodinger M., Mannhalter C., Pabinger I., Koizar D., Rintelen C., Horl W.H., et al. Resistance to activated protein C (APC): mutation at Arg506 of coagulation factor V and vascular access thrombosis in haemodialysis patients. Nephrol Dial Transplant. 11(4):1996;668-672
28. Prieto L.N., Suki W.N. Frequent hemodialysis graft thrombosis: association with antiphospholipid antibodies. Am J Kidney Dis. 23(4):1994;587-590
29. Brunet P., Aillaud M.F., San Marco M., Philip-Joet C., Dussol B., Bernard D., et al. Antiphospholipids in hemodialysis patients: relationship between lupus anticoagulant and thrombosis. Kidney Int. 48(3):1995;794-800
30. Sallam S., Wafa E., el-Gayar A., Sobh M., Salama O. Anticardiolipin antibodies in children on chronic haemodialysis. Nephrol Dial Transplant. 9(9):1994;1292-1294
31. Prakash R., Miller C.C. 3rd, Suki W.N. Anticardiolipin antibody in patients on maintenance hemodialysis and its association with recurrent arteriovenous graft thrombosis. Am J Kidney Dis. 26(2):1995;347-352
32. Meyers C.M., Seeff L.B., Stehman-Breen C.O., Hoofnagle J.H. Hepatitis C and renal disease: an update. Am J Kidney Dis. 42(4):2003;631-657
33. El-Serag H.B., Hampel H., Yeh C., Rabeneck L. Extrahepatic manifestations of hepatitis C among United States male veterans. Hepatology. 36(6):2002;1439-1445
34. Agnello V., Chung R.T., Kaplan L.M. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med. 327(21):1992;1490-1495
35. D'Amico G. Renal involvement in hepatitis C infection: cryoglobulinemic glomerulonephritis. Kidney Int. 54(2):1998;650-671
36. Tarantino A., Campise M., Banfi G., Confalonieri R., Bucci A., Montoli A., et al. Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis. Kidney Int. 47(2):1995;618-623
37. Fabrizi F., Martin P., Ponticelli C. Hepatitis C virus infection and renal transplantation. Am J Kidney Dis. 38(5):2001;919-934
38. Fabrizi F., Pozzi C., Farina M., Dattolo P., Lunghi G., Badalamenti S., et al. Hepatitis C virus infection and acute or chronic glomerulonephritis: an epidemiological and clinical appraisal. Nephrol Dial Transplant. 13(8):1998;1991-1997
39. Pouteil-Noble C., Maiza H., Dijoud F., MacGregor B. Glomerular disease associated with hepatitis C virus infection in native kidneys. Nephrol Dial Transplant. 15(Suppl 8):2000;28-33
40. Stehman-Breen C., Alpers C.E., Couser W.G., Willson R., Johnson R.J. Hepatitis C virus associated membranous glomerulonephritis. Clin Nephrol. 44(3):1995;141-147
41. Niu M.T., Coleman P.J., Alter M.J. Multicenter study of hepatitis C virus infection in chronic hemodialysis patients and hemodialysis center staff members. Am J Kidney Dis. 22(4):1993;568-573
42. Fabrizi F., Martin P., Dixit V., Brezina M., Cole M.J., Gerosa S., et al. Quantitative assessment of HCV load in chronic hemodialysis patients: a cross-sectional survey. Nephron. 80(4):1998;428-433
43. Nakayama E., Akiba T., Marumo F., Sato C. Prognosis of anti-hepatitis C virus antibody-positive patients on regular hemodialysis therapy. J Am Soc Nephrol. 11(10):2000;1896-1902
44. Pereira B.J., Natov S.N., Bouthot B.A., Murthy B.V., Ruthazer R., Schmid C.H., et al. for the New England Organ Bank Hepatitis C Study Group Effects of hepatitis C infection and renal transplantation on survival in end-stage renal disease. Kidney Int. 53(5):1998;1374-1381
45. Mathurin P., Mouquet C., Poynard T., Sylla C., Benalia H., Fretz C., et al. Impact of hepatitis B and C virus on kidney transplantation outcome. Hepatology. 29(1):1999;257-263
46. Eknoyan G. The importance of early treatment of the anaemia of chronic kidney disease. Nephrol Dial Transplant. 16(Suppl 5):2001;S45-S49
47. Gennari F.J., Segal A.S. Hyperkalemia: An adaptive response in chronic renal insufficiency. Kidney Int. 62(1):2002;1-9
48. Ochs H.R., Greenblatt D.J., Kaschell H.J., Klehr U., Divoll M., Abernethy D.R. Diazepam kinetics in patients with renal insufficiency or hyperthyroidism. Br J Clin Pharmacol. 12(6):1981;829-832
49. Vinik H.R., Reves J.G., Greenblatt D.J., Abernethy D.R., Smith L.R. The pharmacokinetics of midazolam in chronic renal failure patients. Anesthesiology. 59(5):1983;390-394
50. Burch P.G., Stanski D.R. Decreased protein binding and thiopental kinetics. Clin Pharmacol Ther. 32(2):1982;212-217
51. Ickx B., Cockshott I.D., Barvais L., Byttebier G., De Pauw L., Vandesteene A., et al. Propofol infusion for induction and maintenance of anaesthesia in patients with end-stage renal disease. Br J Anaesth. 81(6):1998;854-860
52. Thapa S., Brull S.J. Succinylcholine-induced hyperkalemia in patients with renal failure: an old question revisited. Anesth Analg. 91(1):2000;237-241
53. Beauvoir C., Peray P., Daures J.P., Peschaud J.L., D'Athis F. Pharmacodynamics of vecuronium in patients with and without renal failure: a meta-analysis. Can J Anaesth. 40(8):1993;696-702
54. Bevan D.R., Donati F., Gyasi H., Williams A. Vecuronium in renal failure. Can Anaesth Soc J. 31(5):1984;491-496
55. Cooper R.A., Mirakhur R.K., Wierda J.M., Maddineni V.R. Pharmacokinetics of rocuronium bromide in patients with and without renal failure. Eur J Anaesthesiol Suppl. 11:1995;43-44
56. Szenohradszky J., Fisher D.M., Segredo V., Caldwell J.E., Bragg P., Sharma M.L., et al. Pharmacokinetics of rocuronium bromide (ORG 9426) in patients with normal renal function or patients undergoing cadaver renal transplantation. Anesthesiology. 77(5):1992;899-904
57. Head-Rapson A.G., Devlin J.C., Parker C.J., Hunter J.M. Pharmacokinetics and pharmacodynamics of the three isomers of mivacurium in health, in end-stage renal failure and in patients with impaired renal function. Br J Anaesth. 75(1):1995;31-36
58. Bower S., Sear J.W. Disposition of alfentanil in patients receiving a renal transplant. J Pharm Pharmacol. 41(9):1989;654-657
59. Chauvin M., Lebrault C., Levron J.C., Duvaldestin P. Pharmacokinetics of alfentanil in chronic renal failure. Anesth Analg. 66(1):1987;53-56
60. Hoke J.F., Shlugman D., Dershwitz M., Michalowski P., Malthouse-Dufore S., Connors P.M., et al. Pharmacokinetics and pharmacodynamics of remifentanil in persons with renal failure compared with healthy volunteers. Anesthesiology. 87(3):1997;533-541
61. Szeto H.H., Inturrisi C.E., Houde R., Saal S., Cheigh J., Reidenberg M.M. Accumulation of normeperidine, an active metabolite of meperidine, in patients with renal failure of cancer. Ann Intern Med. 86(6):1977;738-741
62. Angst M.S., Buhrer M., Lotsch J. Insidious intoxication after morphine treatment in renal failure: delayed onset of morphine-6-glucuronide action. Anesthesiology. 92(5):2000;1473-1476
63. Saidman L.J., Eger E.I. Safety of low-flow sevoflurane anesthesia in patients with chronically impaired renal function is not proven. Anesthesiology. 99(3):2003;752. author reply: 752-4
64. Conzen P.F., Kharasch E.D., Czerner S.F., Artru A.A., Reichle F.M., Michalowski P., et al. Low-flow sevoflurane compared with low-flow isoflurane anesthesia in patients with stable renal insufficiency. Anesthesiology. 97(3):2002;578-584
65. Higuchi H., Adachi Y., Wada H., Kanno M., Satoh T. The effects of low-flow sevoflurane and isoflurane anesthesia on renal function in patients with stable moderate renal insufficiency. Anesth Analg. 92(3):2001;650-655
66. Conzen P.F., Nuscheler M., Melotte A., Verhaegen M., Leupolt T., Van Aken H., et al. Renal function and serum fluoride concentrations in patients with stable renal insufficiency after anesthesia with sevoflurane or enflurane. Anesth Analg. 81(3):1995;569-575
67. Cousins M.J., Mazze R.I. Methoxyflurane nephrotoxicity. A study of dose response in man. JAMA. 225(13):1973;1611-1616
68. Kobayashi Y., Ochiai R., Takeda J., Sekiguchi H., Fukushima K. Serum and urinary inorganic fluoride concentrations after prolonged inhalation of sevoflurane in humans. Anesth Analg. 74(5):1992;753-757
69. Goldberg M.E., Cantillo J., Larijani G.E., Torjman M., Vekeman D., Schieren H. Sevoflurane versus isoflurane for maintenance of anesthesia: are serum inorganic fluoride ion concentrations of concern? Anesth Analg. 82(6):1996;1268-1272
70. Morio M., Fujii K., Satoh N., Imai M., Kawakami U., Mizuno T., et al. Reaction of sevoflurane and its degradation products with soda lime. Toxicity of the byproducts. Anesthesiology. 77(6):1992;1155-1164
71. Gonsowski C.T., Laster M.J., Eger E.I. 2nd, Ferrell L.D., Kerschmann R.L. Toxicity of compound A in rats. Effect of a 3-hour administration. Anesthesiology. 80(3):1994;556-565
72. Keller K.A., Callan C., Prokocimer P., Delgado-Herrera L., Friedman M.B., Hoffman G.M., et al. Inhalation toxicity study of a haloalkene degradant of sevoflurane. Compound A (PIFE), in Sprague-Dawley rats. Anesthesiology. 83(6):1995;1220-1232
73. Eger E.I. 2nd, Koblin D.D., Bowland T., Ionescu P., Laster M.J., Fang Z., et al. Nephrotoxicity of sevoflurane versus desflurane anesthesia in volunteers. Anesth Analg. 84(1):1997;160-168
74. Goldberg M.E., Cantillo J., Gratz I., Deal E., Vekeman D., McDougall R., et al. Dose of compound A, not sevoflurane, determines changes in the biochemical markers of renal injury in healthy volunteers. Anesth Analg. 88(2):1999;437-445
75. Eger E.I. 2nd, Gong D., Koblin D.D., Bowland T., Ionescu P., Laster M.J., et al. Dose-related biochemical markers of renal injury after sevoflurane versus desflurane anesthesia in volunteers. Anesth Analg. 85(5):1997;1154-1163
76. Higuchi H., Sumita S., Wada H., Ura T., Ikemoto T., Nakai T., et al. Effects of sevoflurane and isoflurane on renal function and on possible markers of nephrotoxicity. Anesthesiology. 89(2):1998;307-322
77. Groudine S.B., Fragen R.J., Kharasch E.D., Eisenman T.S., Frink E.J., McConnell S. Comparison of renal function following anesthesia with low-flow sevoflurane and isoflurane. J Clin Anesth. 11(3):1999;201-207
78. Mazze R.I., Callan C.M., Galvez S.T., Delgado-Herrera L., Mayer D.B. The effects of sevoflurane on serum creatinine and blood urea nitrogen concentrations: a retrospective, twenty-two-center, comparative evaluation of renal function in adult surgical patients. Anesth Analg. 90(3):2000;683-688
79. Ebert T.J., Frink E.J. Jr., Kharasch E.D. Absence of biochemical evidence for renal and hepatic dysfunction after 8 hours of 1.25 minimum alveolar concentration sevoflurane anesthesia in volunteers. Anesthesiology. 88(3):1998;601-610
80. Ebert T.J., Messana L.D., Uhrich T.D., Staacke T.S. Absence of renal and hepatic toxicity after four hours of 1.25 minimum alveolar anesthetic concentration sevoflurane anesthesia in volunteers. Anesth Analg. 86(3):1998;662-667
81. Ebert T.J., Arain S.R. Renal responses to low-flow desflurane, sevoflurane, and propofol in patients. Anesthesiology. 93(6):2000;1401-1406
82. Bito H., Ikeuchi Y., Ikeda K. Effects of low-flow sevoflurane anesthesia on renal function: comparison with high-flow sevoflurane anesthesia and low-flow isoflurane anesthesia. Anesthesiology. 86(6):1997;1231-1237
83. Kharasch E.D., Frink E.J. Jr., Zager R., Bowdle T.A., Artru A., Nogami W.M. Assessment of low-flow sevoflurane and isoflurane effects on renal function using sensitive markers of tubular toxicity. Anesthesiology. 86(6):1997;1238-1253
84. Litz R.J., Hubler M., Lorenz W., Meier V.K., Albrecht D.M. Renal responses to desflurane and isoflurane in patients with renal insufficiency. Anesthesiology. 97(5):2002;1133-1136
85. Weiskopf R.B., Eger E.I. 2nd, Ionescu P., Yasuda N., Cahalan M.K., Freire B., et al. Desflurane does not produce hepatic or renal injury in human volunteers. Anesth Analg. 74(4):1992;570-574
86. Luciani J., Frantz P., Thibault P., Ghesquierre F., Conseiller C., Cousin M.T., et al. Early anuria prevention in human kidney transplantation. Advantage of fluid load under pulmonary arterial pressure monitoring during surgical period. Transplantation. 28(4):1979;308-312
87. Carlier M., Squifflet J.P., Pirson Y., Gribomont B., Alexandre G.P. Maximal hydration during anesthesia increases pulmonary arterial pressures and improves early function of human renal transplants. Transplantation. 34(4):1982;201-204
88. Thomsen H.S., Lokkegaard H., Munck O. Influence of normal central venous pressure on onset of function in renal allografts. Scand J Urol Nephrol. 21(2):1987;143-145
89. Dawidson I.J., Sandor Z.F., Coorpender L., Palmer B., Peters P., Lu C., et al. Intraoperative albumin administration affects the outcome of cadaver renal transplantation. Transplantation. 53(4):1992;774-782
90. Dawidson I.J., Ar'Rajab A. Perioperative fluid and drug therapy during cadaver kidney transplantation. Clin Transpl. 1992;267-284
91. Dawidson I., Ar'Rajab A., Dickerman R., Husberg B., Klintmalm G., Lu C., et al. Perioperative albumin and verapamil improve early outcome after cadaver renal transplantation. Transplant Proc. 26(6):1994;3100-3101
92. Tiggeler R.G., Berden J.H., Hoitsma A.J., Koene R.A. Prevention of acute tubular necrosis in cadaveric kidney transplantation by the combined use of mannitol and moderate hydration. Ann Surg. 201(2):1985;246-251
93. van Valenberg P.L., Hoitsma A.J., Tiggeler R.G., Berden J.H., van Lier H.J., Koene R.A. Mannitol as an indispensable constituent of an intraoperative hydration protocol for the prevention of acute renal failure after renal cadaveric transplantation. Transplantation. 44(6):1987;784-788
94. Alfrey E.J., Boissy A.R., Lerner S.M. Dual-kidney transplants: long-term results. Transplantation. 75(8):2003;1232-1236
95. Akpek E., Kayhan Z., Kaya H., Candan S., Haberal M. Epidural anesthesia for renal transplantation: a preliminary report. Transplant Proc. 31(8):1999;3149-3150
96. Williams M., Milner Q.J. Postoperative analgesia following renal transplantation - current practice in the UK. Anaesthesia. 58(7):2003;712-713
97. Matas A.J., Humar A., Gillingham K.J., Payne W.D., Gruessner R.W., Kandaswamy R., et al. Five preventable causes of kidney graft loss in the 1990s: a single-center analysis. Kidney Int. 62(2):2002;704-714
98. Humar A., Kerr S.R., Ramcharan T., Gillingham K.J., Matas A.J. Peri-operative cardiac morbidity in kidney transplant recipients: incidence and risk factors. Clin Transplant. 15(3):2001;154-158
99. Djamali A., Becker Y.T., Simmons W.D., Johnson C.A., Premasathian N., Becker B.N. Increasing hematocrit reduces early posttransplant cardiovascular risk in diabetic transplant recipients. Transplantation. 76(5):2003;816-820